$SXTP: 60 Degrees Reports Positive Clinical Results in Expanded Access Babesi

$SXTP

$SXTP – 60 Degrees Reports Positive Clinical Results in Expanded Access Babesiosis Study

60 DEGREES PHARMACEUTICALS, INC.

2026-10-27 00:00:00 UTC · SEC_8K · All $SXTP

?? Positive AI Sentiment (+6.5 / 10)

100% of completed patients (5/5) reported significant clinical improvement and negative conventional PCR tests
80% (4/5) tested negative on sensitive post-treatment NAT testing
Supports tafenoquine combination regimen efficacy in immunocompromised patients